Clinical Notes: Drugs with adverse skeletal effectsCertain drugs can adversely affect the skeleton and increase the risk of osteoporosis or fractures. Clinical Notes: Pediatric captopril formulations vary widely across CanadaVariances makes it difficult to optimize captopril dosing in children, could lead to toxicity. David McLeod new NAPRA president Charlottetown-based pharmacist will serve in role for a one-year term. Design, Build, Provide Care Drug News: June 2011 Byetta: second GLP-1 agonist for diabetes; Gilenya: first oral disease-modifying drug for MS; Nucynta CR: new opioid for moderate—moderate/severe pain. E-records may reduce lawsuits The growing use of electronic records will change the nature of legal liability for healthcare providers Editorial: One foot in front of the other Overcome adversity one step at a time. Editorial: Together is definitely better Finger-pointing and blame-throwing often seems to hold pharmacy back from real success. Harper and healthcare Insect Repellents: Buzz off! Helping patients select and properly use insect repellents. Letters: Discussing Dabigatran I would like to comment on a few points discussed in the article on dabigatran (Medication Forum, April/May 2011). Meet... Jeff Poston A conversation with the long-time executive director of the Canadian Pharmacists Association. First Previous 1748 1749 1750 1751 1752 Next Last
